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Abstract
Background: Neurogenesis in the adult mammalian hippocampus may contribute to repairing the
brain after injury. However, Molecular mechanisms that regulate neuronal cell proliferation in the
dentate gyrus (DG) following ischemic stroke insult are poorly understood. This study was
designed to investigate the potential regulatory capacity of non-receptor tyrosine kinase Src on
ischemia-stimulated cell proliferation in the adult DG and its underlying mechanism.
Results: Src kinase activated continuously in the DG 24 h and 72 h after transient global ischemia,
while SU6656, the Src kinase inhibitor significantly decreased the number of bromodeoxyuridine
(BrdU) labeling-positive cells of rats 7 days after cerebral ischemia in the DG, as well as down-
regulated Raf phosphorylation at Tyr(340/341) site, and its down-stream signaling molecules ERK
and CREB expression followed by 24 h and 72 h of reperfusion, suggesting a role of Src kinase as
an enhancer on neuronal cell proliferation in the DG via modifying the Raf/ERK/CREB cascade. This
hypothesis is supported by further findings that U0126, the ERK inhibitor, induced a reduction of
adult hippocampal progenitor cells in DG after cerebral ischemia and down-regulated phospho-
ERK and phospho-CREB expression, but no effect was detected on the activities of Src and Raf.
Conclusion: Src kinase increase numbers of newborn neuronal cells in the DG via the activation
of Raf/ERK/CREB signaling cascade after cerebral ischemia.
Background
It is well established that the generation of new neurons
continues throughout adulthood in the DG in many spe-
cies of vertebrates [1,2]. The neuronal cell proliferation in
the DG is regulated by several physiological factors,
including enriched environments [3], running [4] and
learning [5]. Reportedly, such pathological states as lesion
and ischemia may result in cell birth in the hippocampal
DG [6,7]. Elegant studies in multiple labs have described
the maturation of newborn cells in the subgranular region
of DG and their eventual incorporation into mature phys-
iologically active dentate granule neurons [8,9]. After
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transient forebrain ischemia, newly generated neurons
migrate and incorporate into functional synaptic circuitry,
which provides a possible therapeutic strategy for
ischemic injury repair [10]. The identification of intracel-
lular signaling events that regulate the rate of ischemia-
induced progenitor cell proliferation is therefore of signif-
icant interest.
The Src family kinases (SFKs) are a family of proteins that
have been implicated in relaying signals as downstream of
a wide variety of cell-surface receptors to regulate diverse
cellular responses including proliferation, differentiation,
survival changes in cellular architecture, and regulating
cell adhesion and migration [11]. Five members of SFKs
(Src, Fyn, Yes, Lck, and Lyn) are known to be expressed in
the mammalian brain [12], of which Src, Fyn, and Yes
have been detected in the developing brain [13]. Further-
more, differentiating rodent neurons express a high level
of Src, which is identified as being important in growth
cone-mediated neurite extension, synaptic plasticity, and
neuronal differentiation [14,15]. The increment in Src
kinase activity observed during the development of stria-
tum and hippocampus is coincident with the peak period
of neurogenesis and neuronal growth [16]. Nevertheless,
its association with ischemia-induced neuronal cell prolif-
eration in the hippocampal DG and potential signal trans-
duction has not been explored.
One signaling cascade implicated in regulating the prolif-
erative capacity of adult stem cells is mitogen-activated
protein kinase (MAPK) [17]. The extracellular signal-regu-
lated kinase (ERK) is a subfamily member of MAPK acti-
vated by an upstream kinase called MAPKKK (Raf)/ERK
kinase (MEK) in response to growth stimuli [18]. Much
evidence exists that the ERK pathway plays a role in pro-
genitor cell proliferation or differentiation in a number of
model systems mediated by alterations of nuclear tran-
scription factors [17]. For example, the ERK pathway is
involved in neurogenesis, neurite outgrowth, and neuro-
nal survival induced by neurotrophic factors [19,20] and
pharmacon like valproate [21] or lithium [22]. Mean-
while, MAPKKK (Raf) is reported to be potently phospho-
rylated by Src kinase at Tyr340/341 residue in
mammalian cells, relieving its autoinhibition [23]. No
data to date is available regarding the question whether
ERK triggers cell proliferation after ischemia in the DG
region of hippocampus as well as the role of Src kinase in
the process.
Non-receptor tyrosine kinase Src plays prominent roles in
ischemic cerebral apoplexy [24]. Ischemic challenge par-
ticularly results in a sustained activation of the Src family
PTKs (primarily Src) in the rat hippocampus [25,26]. In
this study, we propose that sustained activation of Src
kinases plays a key role in progenitor cell proliferation via
Raf/ERK/CREB cascades in hippocampal dentate gyrus
after transient cerebral ischemia.
Results
Src kinase was sustainedly activated in the hippocampal 
DG following ischemia-reperfusion and its inhibitor 
SU6656 prevented ischemia-induced neuronal cell 
proliferation
Our previous studies indicated that cerebral ischemia
induced sustained activation of Src kinase following
ischemia in the hippocampus [25]. In the present study,
we further assessed the activity of Src kinase of DG/CA3
subfield after 24 h reperfusion post-ischemia. Based on
that the phosphorylation of Src C-terminal Tyr-527 resi-
due expresses a down-regulated kinase state, anti-Src
Tyr527 antibody was employed, as exhibited in Fig. 1A (P
< 0.05), the activity of Src remained in a high level until
24 h and 72 h reperfusion illustrated by strong dephos-
phorylation of Src at Tyr527 site compared with sham
operated animals. It suggested that continuous Src kinase
activation may be involved in triggering some pathologi-
cal phenomena in the DG/CA3 region induced by
ischemia and reperfusion. As has been well accepted,
ischemia stimulates neurogenesis in the DG; thus we
explored the possibility of Src being involved in the pro-
liferation of adult hippocampal progenitor cells. SU6656,
an inhibitor of Src kinases, was administered into cerebral
ventricle before ischemia, and found to be effective in sup-
pressing Src activity (P < 0.05, Fig. 1A). On day 7 post
ischemia, the number of BrdU-positive cells was shown to
be approximately 4-fold larger in the ischemic group than
that in the sham group. BrdU-labeled cells in each group
were located exclusively in the SGZ in clusters (P < 0.05,
Fig. 1B - a, b). Importantly, we demonstrated that SU6656
decreased the number of BrdU - positive cells after
ischemia (P < 0.05, Fig. 1B - c). The solvent had no influ-
ence on the number of BrdU-positive cells on the 7th post-
ischemic day as opposed to the ischemic group (Fig. 1B -
d). Based on the results, we surmise that Src kinases may
be implicated in the ischemia-induced cell proliferation
in the hippocampal DG.
SU6656 inhibit Raf (340/341)/ERK/CREB cascade in the 
DG after ischemia
For a better understanding of the down-stream signaling
mechanism of Src on cell proliferation stimulated by
ischemia, some signaling proteins relating to growth like
ERK or CREB were examined in the following way. First,
we attempted to see whether the alteration of Src kinases
affected the ischemia-induced ERK activity in the areas of
CA3 and DG. We selected two time spots (24 h and 72 h).
At both spots the amount of p-ERK increased at least two-
fold when compared with sham control group; while the
elevated level of p-ERK lowered in the SU6656 - treated
rats (P < 0.05, Fig. 2A), and the solvent group showed noBMC Neuroscience 2009, 10:139 http://www.biomedcentral.com/1471-2202/10/139
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change in the phosphorylation of ERK after ischemia and
reperfusion(P > 0.05, Fig. 2A). These results suggest that
ERK phosphorylation in the DG region triggered by
ischemia depends on Src activation. To further explore
how Src kinase induced ERK activation, we examined the
effects of SU6656 on Raf activity in CA3 and DG fields fol-
lowing ischemia. Raf, an up-stream kinase of ERK, is
thought to be activated by its Tyr340/341 - phosphoryla-
tion. As demonstrated in (P < 0.05, Fig. 2B), drastic phos-
phorylation of Raf at these residues was observed after 24
h and 72 h reperfusion. SU6656, rather than the solvent,
markedly attenuated the effect (P < 0.05, Fig. 2B), indicat-
ing that Src kinase may trigger the activation of ERK via
phosphorylation of Raf at its Tyr340/341 residues after
ischemia and reperfusion. Besides, another protein CREB,
a transcription factor involved in the cell proliferation in
various models, was assessed. The phosphorylated level of
CREB (Ser133) grew after the 24 h and 72 h reperfusions
respectively, but strikingly down-regulated at both time
spots in the group of SU6656. The vehicle-treated group
kept unchanged (P < 0.05, Fig. 2C), suggesting a role of
CREB in Src-dependent cell proliferation after ischemia.
On the other hand, the presence of the SU6656 and its
solvent did not alter the level of total ERK, Raf and CREB
proteins (Fig. 2A, B and 2C). Therefore, our study revealed
the involvement of Src kinase in the regulation of Raf/ERK
and CREB cascade in the DG fields after ischemia.
Src kinase sustainedly activated in the DG field of hippocampus after ischemia, while its inhibitor SU6656 blocked cell prolifer- ation induced by ischemia Figure 1
Src kinase sustainedly activated in the DG field of hippocampus after ischemia, while its inhibitor SU6656 
blocked cell proliferation induced by ischemia. SU6656 was intracerebroventricularly (i.c.v) administratered 20 min 
before ischemia. (A) Western blot for Src kinase detected by anti-p-Src antibody (Tyr527). (B) DAB staining for Brdu-positive 
cells in the SGZ of dentate gyrus. (a) Sham rats (n = 4), (b) Rats with 7 days of reperfusion postischemia (n = 5), (c) SU6656-
treated ischemic rats (n = 5), and (d) vehicle-treated ischemic rats (n = 4). *P < 0.05 vs. sham group; #P < 0.05 or aP < 0.05 vs. 
the respective reperfusion group. Bar: 200 μm.BMC Neuroscience 2009, 10:139 http://www.biomedcentral.com/1471-2202/10/139
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U0126 block generation of new neurons in the DG through 
inhibition of ERK/CREB cascade after cerebral ischemia
To determine whether ERK pathway participate in cell
proliferation of DG induced by ischemia, we used U0126
as its inhibitor after being infused into bilateral cerebral
ventricle, and it turned out to be effective in depressing
ERK activity (P < 0.05, Fig. 3A). Consistent with our expec-
tation, we demonstrated that U0126 had a similar effect
on SU6656, which significantly decreased the number of
BrdU-labeled cells in the SGZ of DG field 7 days after
ischemia (P < 0.05, Fig. 3B - a, b and 3Bd). The solvent of
the U0126 group did not change the number of new born
neurons following ischemia-reperfusion. These results
indicate that SU6656 inhibited cell proliferation through
down-regulated phosphorylation of ERK in the DG field.
Subsequently, we observed the effects of U0126 on CREB
activation after ischemia-reperfusion in the fields of CA3
and DG. The data showed that rats treated with U0126
before ischemia had lower phosphorylated level of CREB,
in comparison with the 24 h reperfusion rats (P < 0.05,
Fig. 3C), suggesting that CREB might be contributed to
ERK dependent neural cell proliferation after ischemia.
Activities of Src and Raf after U0126 treatment in the DG
following ischemia showed that down-regulation of ERK
had no relation to Src and Raf phosphorylation on these
very residues at the time period of maximum stimulation
of Src/Raf (P > 0.05, Fig. 3D and 3E), further proving that
Src/Raf cascade was an upstream mediator for ERK activa-
tion. The solvent of U0126 exhibited no alterations on
phosphorylation of ERK, Src, Raf and CREB after 24 h
Inhibiting the activation of Src kinase by SU6656 down-regulate Raf (Y340)/ERK/CREB cascade after ischemia- reperfusion Figure 2
Inhibiting the activation of Src kinase by SU6656 down-regulate Raf (Y340)/ERK/CREB cascade after ischemia- 
reperfusion. Samples were used as in Fig. 1. (A) Raf phosphorylation at Tyr340/341. (B) ERK phosphorylation at Thr202/
Tyr204. (C) CREB phosphorylation at Ser133. Data are expressed as mean ± S.D. (n = 4/group) *P < 0.05 vs. sham group, #P < 
0.05 vs. respective reperfusion group.BMC Neuroscience 2009, 10:139 http://www.biomedcentral.com/1471-2202/10/139
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Inhibition on activated ERK blocked ischemia-stimulated cell proliferation in the dentate gyrus and CREB activation, but it did  not affect expression of p-Src and p-Raf Figure 3
Inhibition on activated ERK blocked ischemia-stimulated cell proliferation in the dentate gyrus and CREB acti-
vation, but it did not affect expression of p-Src and p-Raf. U0126 was intracerebroventricularly (i.c.v) administratered 
20 min before ischemia. (A) ERK phosphorylation after reperfusion 24 h post ischemia.(B) DAB staining for BrdU-positive cells 
in the SGZ at the 7th post-ischemic day. (a) Rats with 7 days of reperfusion after ischemia (n = 5), (b) U0126-treated ischemic 
rats (n = 4), (c) vehicle-treated ischemic rats (n = 4), and (d) SU6656-treated ischemic rats (n = 5). (C) CREB phosphorylation, 
(D) Src phosphorylation or (E) Raf phosphorylation. Data are expressed as mean ± S.D. *P < 0.05 vs. sham, #P < 0.05 or aP < 
0.05 vs. respective reperfusion. Bar: 200 μmBMC Neuroscience 2009, 10:139 http://www.biomedcentral.com/1471-2202/10/139
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reperfusion, and no variation was detected in the total
ERK, Src, Raf and CREB level in all the groups (Fig. 3A-E).
The above results are suggestive of a key role of Src-stimu-
lating Raf (Tyr340/341)/ERK/CREB pathway in the
ischemia-induced hippocampal cell proliferation.
Neurons of DG subfields are resistant to ischemia injury, 
and activation of Src but not ERK promote delayed 
neuronal death of CA1 region
Transient global cerebral ischemia leads to neuronal
death of hippocampus. To investigate whether survival of
hippocampal neurons was affected by SU6656 or U0126,
NISSL staining was performed to detect hippocampal neu-
rons in the rats subjected to 5 days of reperfusion follow-
ing ischemia (I/R5d). Under a light microscope, the
normal neurons showed round cell bodies and plain
stained nuclei (Fig. 4A). After 5 days of reperfusion fol-
lowing brain ischemia, though the regions of CA3 and DG
were shown to be the same as in the sham group and no
damaged cell was detectable, a prominent neuronal loss
was observed and the few pyramidal neurons left were
shrunken with pyknotic nuclei in the hippocampal CA1
region (P < 0.05, Fig. 4B). However, administration with
SU6656 before ischemia markedly increased the survival
of neurons in the hippocampal CA1 region (P < 0.05, Fig.
4C - CA1), while infusion of U0126 (P > 0.05, Fig. 4D -
CA1) or the solvent (P > 0.05, Fig. 4E - CA1) did not alle-
viate post-ischemic cell death. Statistical analysis of neu-
ronal density for each group is shown in (Fig. 4). Besides
increasing cell proliferation of DG, activation of Src also
participated in pyramidal cell death in CA1 triggered by
ischemia, but Src/Raf/ERK cascade only explained the new
cell birth in the DG.
Discussion
Cerebral ischemia insults have been shown to trigger pro-
liferation of endogenous neural stem cells or progenitor
cells located in the hippocampal dentate gyrus [27,28],
and the number of neuronal stem cells increased obvi-
ously 5-7d after ischemia [22,28]. The pathological mech-
anism of ischemia is regulated by a variety of protein
tyrosine kinases. Some of these kinases, including FGF,
BDNF and NGF receptors, have been reported to be
involved in ischemia-stimulated neurogenesis [29]. How-
ever, the roles of non receptor tyrosine kinases (mainly is
Src) remain unclear. An earlier study reported that activa-
tion of Src kinase is related to hippocampal neurogenesis
beginning in late embryonic life and continuing for some
period of time after birth [16]. Recent studies indicate that
Src activation is required for muscarinic receptor-medi-
ated DNA synthesis and cell proliferation in neural pre-
cursor cells [30]. Interestingly, our present findings
demonstrated that cerebral ischemia stimulated a sus-
tained activation of Src kinase in the DG region, and
SU6656, the Src specific inhibitor, significantly decreased
the number of BrdU - positive cells of DG after 7 days of
reperfusion (Fig. 1B). Thus, we suppose that Src activation
following stroke insult is responsible for ischemia-
induced cell proliferation in the dentate gyrus.
The molecular mechanism underlying Src kinase depend-
ent neural cell proliferation stimulated by ischemia is
complex. Signals that increase intracellular Ca2+ concen-
tration serve as a main contributing factor for activation of
Src [31], which, as a cytoplasmic non receptor tyrosine
kinase, acts like a relay station that transmits various sig-
nals to their specific targeted downstream molecules to
modulate transcriptional activation and mitogenesis.
Under some conditions, ERK has been demonstrated as
one of the key downstream signals of Src kinase. The prob-
lem is whether ERK participates in the generation of new
adult progenitor cells or not and whether its role is posi-
tive or negative, which awaits further exploration. Our
previous studies showed that cerebral ischemia stimulated
a sustained activation of ERK in the DG field of hippoc-
ampus [25,26], and in the present study the elevation was
found lasting at least 72 h after ischemia (Fig. 2A), which
is roughly coincident with activation of Src kinase
(Fig.1A). Several studied have demonstrated that both
ERK and Src immunoreactivity were enhanced in the DG
after ischemic insult [32-34], suggesting that there may
exists a relationship between the two. This presumption is
supported by the detection of Raf, the well accepted ERK
cascades upstream kinase, whose residues Tyr 340/341 are
directly phosphorylated by Src after ischemia (Fig. 2B),
and it is consistent with the view from Alavi [23]. While
recent findings suggested that ERK signaling participated
in hypoxia-induced neurogenesis in vitro [35,36], in this
study, our data showed that blocking the activation of
ERK diminished the ischemia-promoted increase in adult
hippocampal progenitor cells of rats (Fig. 3B-a, b), and it
further proved that ERK was of great significance in medi-
ating cell proliferation the DG. Taken together, it is con-
vincing to suggest that Src participating in the
regeneration of adult hippocampal progenitor cells trig-
gered by ischemia is through mediating the Raf/ERK cas-
cades. CREB is a basic leucine zipper family transcription
factor that mediates diverse responses in the nervous sys-
tem [37]. Our data showed that ischemia also caused con-
tinuous activation of CREB in the DG region of
hippocampus (Fig. 2C), and inhibition of Src/Raf/ERK
pathway by SU6656 and U0126, both of which signifi-
cantly decreased the p-CREB level (Fig. 2C; Fig. 3C).
Meanwhile, there is abundant evidence that CREB is
involved in the progress of differentiation and survival, as
well as proliferation, of progenitor cells in adult hippoc-
ampus [38-40]. More importantly, some recent studies in
rats demonstrated that activation of CREB after cerebral
ischemia stimulated cell proliferation in the adult DG
[28]. Our results indicated that both Src- and ERK-BMC Neuroscience 2009, 10:139 http://www.biomedcentral.com/1471-2202/10/139
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The region of DG is resistant to ischemic damage while CA1 is vulnerable Figure 4
The region of DG is resistant to ischemic damage while CA1 is vulnerable. Blockage activation of Src instead 
of ERK significantly decreased neuronal loss in hippocampal CA1 after ischemia. NISSL staining was performed to 
examine the survival of hippocampal neurons following 5 days reperfusion. (A) sham group, (B) 5 days of reperfusion pos-
tischemia (R5d), (C) SU6656 administration, (D) U0126 administration, and (E) vehicle administration (n = 5). Data are 
expressed as means ± S.D. *P < 0.05 versus sham; #P < 0.05 versus I/R 5 days groups (n = 5). Scale bars in A-E = 200 μm; bars 
in CA1 and DG = 20 μm.BMC Neuroscience 2009, 10:139 http://www.biomedcentral.com/1471-2202/10/139
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dependent proliferations of adult hippocampal progeni-
tor cells were mediated by activation of CREB, and pro-
vided further proof that Src/Raf/ERK cascade was involved
in neural cell proliferation evoked by ischemia in DG.
In addition, ischemia insult may also trigger others molec-
ular pathways, which may associate with altering prolifer-
ation of progenitor cells. The results (in Fig. 3B) showed
there was a distinction between blockage of p - Src and
that of p - ERK in the number of DG BrdU-labeling cells,
indicating that beside Raf/ERK cascade, there might be
some other factors triggered by Src getting involved in this
event, such as PI3K/Akt pathway which has also been
known to be activated by Src kinase following ischemia/
reperfusion in various organs, and plays a pivotal role in
cell proliferation, differentiation, and survival [41-43].
On the other hand, one possible mechanism underlying
brain ischemia-induced proliferation of neural progeni-
tors is stimulation of tyrosine kinase-coupled receptors by
induction of growth factors such as FGF, BDNF and NGF
[29]. Brain ischemia-induced cell proliferation is triggered
by ERK activation through expression of growth factors
and cognate receptors in the DG [29,44]. this report may
be explain the phenomenon in our results, CREB phos-
phorylation is still considerably up-regulated even after
SU6656 inhibition compared to the control, and the
effects of U0126 upon CREB is much more remarkable.
But how these molecular signals concordantly regulate
each other, and their contribution in the birth of progen-
itor cells are unknown, which remain further research.
It is generally accepted that the region of DG is relatively
resistant to ischemic injury. Our result also validated that
there is no ischemia - induced neuronal death in the DG
fields (Fig. 4B-DG). Thus we assume that sustained activa-
tion of Src kinase may not interfere with survival of neu-
rons in DG fields after ischemia. However, cerebral
ischemia triggers neuronal death in CA1 of hippocampus,
and our data suggested Src activation also played a key
role in CA1 pyramidal cell death after ischemia (Fig. 4C -
CA1). We are therefore confused about which was the key
factor in stimulating cell proliferation of DG region, Src
kinase or neuronal damage in CA1, as both regions of DG
and CA1 were related to activation of Src but with differ-
ent kinds of neuronal destiny after ischemia. Considering
that blockage of activation of ERK did not reduce neuro-
nal death rate of CA1 fields (Fig. 4D - CA1), we suppose
that the proliferation of adult progenitor cells in DG is not
directly related to injury in the CA1 region evoked by
ischemia, and that the different fates of neurons suffering
ischemia between DG and CA1 are determined by differ-
ent signaling pathway-dependent activations of Src
kinase. What's more, the Raf/ERK/CREB cascade only
mediates cell proliferation of DG but has no association
with neuronal death of CA1 after ischemia.
Conclusion
Following cerebral ischemic insults, the marked stimula-
tion of neuronal cell proliferation by Src mechanisms in
the dentate gyrus is partly mediated through the cascade
from Ca2+ influx to Raf/ERK activation, and then to CREB
phosphorylation, which, in turn, triggers genes related to
cell proliferation expression (Fig. 5).
Methods
Animals and Induction of ischemia
All animal experiments were carried out in accordance
with the Institutional Animal Care and Use Committee
and conformed to international guidelines on the ethical
use of animals (Guide for the Care and Use of Laboratory
Animal, 1996). The animals used in the present study
were male Sprague-Dawley rats (Shanghai Experimental
Animal Center, Chinese Academy of Science) weighing
250-300 g, maintained in individual cages with a 12-h
light/dark cycle (lights on from 08:00-20:00). Transient
global cerebral ischemia was induced using four-vessel
occlusion as described previously [25]. Rats were anesthe-
tized with intraperitoneal administration of chloral
hydrate (300 mg/kg, i.p.). Both vertebral arteries were per-
manently electrocauterized at the level of the first cervical
vertebra within the alar foramina, and a small-diameter
silk thread was placed around each carotid artery to facil-
itate subsequent occlusion. Twenty-four hours after electr-
ocauterization, common bilateral carotid arteries were
clamped with microaneurysm clamps for 10 min in ani-
mals which were awake and spontaneously ventilated, at
which time the clips were removed and the rat was
allowed to recover. Rats lost their righting reflex within 30
s and those whose pupils were dilated and unresponsive
to light were selected for the experiments. Rectal tempera-
ture was maintained at about 37°C during and after
ischemia. Sham-operated control rats received an identi-
cal procedure without arterial occlusion.
Drugs and drug treatments
SU6656 (2-oxo-3-(4, 5, 6, 7-tetrahydro-1H-indol-2-
ylmethylene)-2,3- dihydro-1H-indole-5-sulfonic acid
dimethylamide) is an inhibitor of the Src family tyrosine
kinases (Calbiochem, La Jolla, CA, USA). U0126 (1,4-
Diamino-2,3-dicyano-1,4-bis(o-aminophenylmer-
capto)butadiene) is a potent inhibitor of MEK/ERK (Cell
Signaling; USA). 1 μl of dimethyl sulfoxide (DMSO) in 4
μl of phosphate-buffered saline (PBS, PH 7.4) as vehicle
or SU6656 (100 pmol/animal) or U0126 (1 nmol/ani-
mal) was administered using a microinjector into the left
cerebral ventricle (from the bregma: anteroposterior, -0.8
mm; lateral, 1.5 mm; depth, -3.5 mm) over 5 min or its
vehicle. After the injection, the injector was left in place
for an additional 5 min to reduce any possible backflow
of the liquid along with the injection void, and occlusion
occurred 20 min post the injection. BromodeoxyuridineBMC Neuroscience 2009, 10:139 http://www.biomedcentral.com/1471-2202/10/139
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(5-bromo-2-deoxyuridine, BrdU), a synthetic nucleoside
and an analogue of thymidine commonly used in the
detection of proliferating cells in living tissues, was
administered by intraperitoneal injections (50 mg/kg
body weight at a concentration of 7 mg/ml in sterile
saline, Sigma, USA) twice daily during days 5 - 7 after 10
min ischemia or sham operation. The animals were put to
death 24 h after the last injection of BrdU.
Production of protein extracts and Western blotting
For biochemical studies, rats were killed by decapitation
at various times post the reperfusion (24 h, 72 h). The hip-
pocampi were quickly removed on ice in a cold room and
the hippocampal CA3/DG subfields were dissected on ice
as described previously (Guo et al., 2006). The separated
brain regions were homogenized in 1:10 (w/v) ice-cold
homogenization buffer A (HEPES 50, pH 7.4, KCl 100,
Na3VO4 1, NaF 50, PMSF 1 mM) supplemented with 1%
mammalian protease inhibitor cocktail (Sigma-Aldrich
Co.). Proteins in the cytoplasm and membrane were
extracted by centrifugation at 800 × g at 4°C and those in
the nucleus were obtained by centrifugation at 14000 × g
at 4°C in homogenization buffer B (HEPES 50, pH 7.4,
KCl 100, Na3VO4 1, NaF 50, NP40 1, PMSF 1 mM, 0.5%
SDS and 1% cocktail) and then stored at -80°C until
assayed. Protein concentrations were determined by a
Bradford protein assay [45]. Denatured samples from the
extracts (30~40 μg protein) were separated by 10% SDS-
Suggested pathways through which Src kinase regulates cell proliferation in the DG after ischemia Figure 5
Suggested pathways through which Src kinase regulates cell proliferation in the DG after ischemia. Transient 
global ischemia triggered sustained activation of Src kinase by intracellular Ca2+ influx via NMDA and L-VGCC or released from 
ER and mitochondria. Subsequently, activated Src induced continuous phosphorylation of ERK through direct phosphorylation 
of Raf-1 at its Tyr 340/341, and in turn, was translocated from the cytosol to the nucleus where it regulated transcription via 
CREB and some genes relating to cell proliferation expression.BMC Neuroscience 2009, 10:139 http://www.biomedcentral.com/1471-2202/10/139
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polyacrylamide gels and then electrophoretically trans-
ferred to nitrocellulose filter membranes (NC, pore size,
0.2 μm, Amersham Biosciences, Piscataway, NJ, USA). The
filters were probed with the following antibodies at room
temperature for 4 h: rabbit polyclonal anti-Src (1:1000),
rabbit monoclonal anti-phospho-Src (Tyr527, 1:1000),
mouse polyclonal anti-MAP kinase (1:2000), mouse
monoclonal anti-phospho MAP kinase (Thr202/Tyr204,
1:1000), mouse monoclonal anti-phospho-CREB
(Ser133, 1:1000), rabbit monoclonal anti-CREB (1:1000)
from Cell Signaling Technology (Beverly, MA, USA), rab-
bit polyclonal anti-phospho-Raf (Tyr340/341, 1:1000)
from Calbiochem, mouse monoclonal anti-c-Raf
(1:1000) from BD PharMingen (Torrey Pines, CA, USA),
and rabbit polyclonal anti-β-actin (1:500) from Boster
Biotechnology (WuHan, China). Detection was carried
out using horseradish peroxidase (HRP) - conjugated goat
anti-rabbit IgG (1:5000, Santa Cruz) and goat anti-mouse
IgG (1:5000, ZhongShan Golden Bridge Biotechnology,
Beijing, China) and developed via enhanced chemilumi-
nescence (Amersham Biosciences). The optical density of
the band in each lane was expressed as fold versus levels
from sham operated tissue on the same filter.
Fixation, Tissue sample preparation and Nissl staining
Rats were deeply anaesthetized with chloral hydrate (300
mg/kg, i.p.) and transcardially perfused with 300 ml
saline, followed by 500 ml 4% cold paraformaldehyde in
PBS. Brains were removed, post-fixed overnight at 4°C in
same solution and then sliced at 40 μm using a vibratome
in a bath of physiological saline collected free-floating
and stored in 30% ethylene glycol, 30% glycerol, and 0.1
M PBS at - 20°C until processed for immunostaining.
Some sections were processed for staining with Toluidine
blue (Nissl staining) for histological assessment of dam-
age.
Immunohistochemistry
For the detection of BrdU immunoreactivity, DNA dena-
turation was conducted by incubating sections in 50%
formamide and 2× sodium citrate solution for 2 h at
65°C, followed by incubation in 2 N HCl for 30 min.
Then sections were incubated for 10 min in 0.1 M borate
buffer. After being washed in PBS, sections were incubated
in 1% H2O2 for 30 min for the removal of endogenous
peroxidases. After several rinses in PBS, sections were
incubated in PBS/0.2% Triton X-100/5% goat serum
(PBS-TS) for 30 min and then incubated with polyclonal
sheep anti-BrdU (Biotin) (1:1000; Abcam, Cambridge,
UK) overnight at 4°C. After several rinses in PBS - TS, sec-
tions were incubated for 30 min with a streptavidin - HRP
complex (1:100; Boster Biotechnology; WuHan, China).
BrdU positive (BrdU+) cells were labeled using DAB as
chromogen (Zhong Shan -Golden Bridge Biological Tech-
nology; Beijing, China). The labeling was imaged with a
confocal laser - scanning microscope (Olympus LSM-
GB200; Tokyo, Japan) and analyzed with Image-Pro Plus
software (Media Cybernetics, Silver Spring, MD, USA).
Cell counting
To count BrdU - labeled cells after immunohistochemis-
try, the analysis was conducted using a modified version
of the optical fractionator method, on every sixth section
in a series of 40 μm coronal sections [46]. All BrdU -
labeled cells in the subgranular zone (SGZ) and hilus were
counted by an experimenter that was blinded to the code
of the sections. BrdU-positive cells regardless of size or
shape were visualized and counted through an Olympus
BX50 microscope (Olympus, Tokyo, Japan).
To quantitate the survival rate of hippocampal neurons
after Nissl staining, cell counts were performed as
described previously [47,48]. A rectangular grid housed in
one eyepiece was superimposed over 3 medial-lateral sec-
tors (i.e. medial, middle and lateral) of the dorsal CA1
subfield at a level corresponding to the anterior hippoc-
ampus (- 1.7 mm posterior to bregma). Only cells with an
intact cell membrane, a well-defined nucleus and nucleo-
lus were counted. Using these criteria, the number of nor-
mal neurons across all 3 medial - lateral sectors of the CA1
subfield from both hemispheres was summed to yield
total CA1 cell counts for each animal.
Statistical analysis
All data are expressed as mean ± SEM from animals. Sta-
tistical significance was assessed by one-way analysis of
variance (ANOVA) with the least significant difference test
using SPSS software version 10.0. Values of P < 0.05 were
considered statistically significant.
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